REBOUND OBESITY AFTER GLP-1 AGONISTS DISCONTINUATION. Glob. j. public health med. [Internet]. 2025 Jul. 22 [cited 2026 Apr. 21];7(1):208-15. Available from: https://www.gjphm.org/index.php/gjphm/article/view/336